David Henrique Rodrigues1, Daniela Sachs, Antonio Lucio Teixeira. 1. Laboratório de Imunofarmacologia, Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brasil.
Abstract
BACKGROUND: Pain is an important clinical manifestation in multiple sclerosis (MS) patients, though it has been neglected in clinical and experimental researches. OBJECTIVE: To investigate the nociceptive response in MOG35-55 experimental autoimmune encephalomyelitis (EAE)-induced mice. METHOD: EAE was induced in 8 to 10 week old C57BL/6 female mice with an emulsion of MOG35-55, Complete Freund Adjuvant, Mycobacterium tuberculosis H37 RA and pertussis toxin. Nociception was evaluated by the von Frey filaments method. A clinical scale ranging from 0 to 15 was used to assess motor impairment. RESULTS: Clinical evidence of disease started at day 10 and peaked at day 14 after immunization. Thereafter, there was no worsening of symptoms until day 26. The EAE-induced mice presented reduced pressure threshold at days 7th and 10th after immunization and before the onset of clinical motor signs. CONCLUSION: The hypernociception found validates MOG35-55 EAE as a model for the study of pain in multiple sclerosis.
BACKGROUND:Pain is an important clinical manifestation in multiple sclerosis (MS) patients, though it has been neglected in clinical and experimental researches. OBJECTIVE: To investigate the nociceptive response in MOG35-55 experimental autoimmune encephalomyelitis (EAE)-induced mice. METHOD: EAE was induced in 8 to 10 week old C57BL/6 female mice with an emulsion of MOG35-55, Complete Freund Adjuvant, Mycobacterium tuberculosis H37 RA and pertussis toxin. Nociception was evaluated by the von Frey filaments method. A clinical scale ranging from 0 to 15 was used to assess motor impairment. RESULTS: Clinical evidence of disease started at day 10 and peaked at day 14 after immunization. Thereafter, there was no worsening of symptoms until day 26. The EAE-induced mice presented reduced pressure threshold at days 7th and 10th after immunization and before the onset of clinical motor signs. CONCLUSION: The hypernociception found validates MOG35-55 EAE as a model for the study of pain in multiple sclerosis.
Authors: Samuel S Duffy; Brooke A Keating; Chamini J Perera; Justin G Lees; Ryan S Tonkin; Preet G S Makker; Pascal Carrive; Oleg Butovsky; Gila Moalem-Taylor Journal: J Neurosci Date: 2019-01-16 Impact factor: 6.167
Authors: Suzanne Doolen; Tommaso Iannitti; Renee R Donahue; Benjamin C Shaw; Carolyn M Grachen; Bradley K Taylor Journal: Pain Date: 2018-02 Impact factor: 7.926
Authors: Samuel S Duffy; Chamini J Perera; Preet G S Makker; Justin G Lees; Pascal Carrive; Gila Moalem-Taylor Journal: Front Immunol Date: 2016-09-22 Impact factor: 7.561
Authors: Jianning Lu; Martina Kurejova; Laura N Wirotanseng; Ralf A Linker; Rohini Kuner; Anke Tappe-Theodor Journal: J Neuroinflammation Date: 2012-10-06 Impact factor: 8.322